Purple Biotech Ltd - ESG Rating & Company Profile powered by AI
The analysis of Purple Biotech Ltd is prepared by All Street Sevva using advanced AI. The page includes a questions and answers section on Purple Biotech Ltd. Complete Sustainability assessment of Purple Biotech Ltd can be reached by signing in.
Purple Biotech Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 4.8, social score of 6.0 and governance score of 2.0.
4.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 910 | Vaxcyte Inc | 4.4 | High |
| 910 | Yield10 Bioscience Inc | 4.4 | High |
| 951 | Purple Biotech Ltd | 4.3 | High |
| 951 | Cerecor Inc | 4.3 | High |
| 951 | Allergy Therapeutics PLC | 4.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Purple Biotech Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Purple Biotech Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Purple Biotech Ltd report the average age of the workforce?
Sign up for free to unlockDoes Purple Biotech Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Purple Biotech Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Purple Biotech Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Purple Biotech Ltd offer flexible work?
Sign up for free to unlockDoes Purple Biotech Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Purple Biotech Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Purple Biotech Ltd conduct supply chain audits?
Sign up for free to unlockDoes Purple Biotech Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Purple Biotech Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Purple Biotech Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Purple Biotech Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Purple Biotech Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Purple Biotech Ltd disclose water use targets?
Sign up for free to unlockDoes Purple Biotech Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Purple Biotech Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Purple Biotech Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Purple Biotech Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Purple Biotech Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Purple Biotech Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Purple Biotech Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Purple Biotech Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Purple Biotech Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Purple Biotech Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Purple Biotech Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Purple Biotech Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Purple Biotech Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Purple Biotech Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Purple Biotech Ltd disclose its waste policy?
Sign up for free to unlockDoes Purple Biotech Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Purple Biotech Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Purple Biotech Ltd disclose energy use targets?
Sign up for free to unlockDoes Purple Biotech Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Purple Biotech Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Purple Biotech Ltd
These potential risks are based on the size, segment and geographies of the company.
Purple Biotech Ltd. is a clinical-stage company focused on advancing therapies to overcome tumor immune evasion and drug resistance to create treatments for cancer patients in the United States. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension. Its oncology pipeline includes NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer; and CM24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. was founded in 2010 and is headquartered in Rehovot, Israel.